Intelligence

Utilities

BioLargo Achieves Breakthrough in PFAS Removal with New Technology

Author:
FAQsIR News Desk
Last Updated:
Reading Time
2 min

#Introduction to BioLargo's Breakthrough

BioLargo, Inc., based in Westminster, California, has announced a significant advancement in environmental technology, achieving over 99% removal of ultrashort-chain per- and polyfluoroalkyl substances (PFAS). This includes the notoriously resilient trifluoroacetic acid (TFA), utilizing their proprietary Aqueous Electrostatic Concentration (AEC) technology.

#What Are Ultrafast-chain PFAS?

Ultrashort-chain PFAS, particularly TFA, are challenging contaminants due to their small molecular size and high solubility, making them difficult to eliminate using conventional treatment methods. Research published in Environmental Science & Technology revealed that TFA constituted over 90% of the PFAS mass found in various drinking water sources in Germany, highlighting the urgency of effective remediation technologies.

#Aqueous Electrostatic Concentration Technology

The AEC technology developed by BioLargo employs electrostatic forces to attract and isolate charged contaminants from water. This innovative approach enables highly efficient treatment, with internal and third-party testing confirming removal rates exceeding 99% for TFA and other ultrashort-chain PFAS.

#Environmental and Commercial Implications

BioLargo's solution distinguishes itself by not generating harmful byproducts or secondary waste streams, presenting a sustainable option for tackling PFAS contamination. Following the successful validation of its performance, the company is engaging in discussions with potential partners to expand its commercial footprint in North America, aiming to leverage this technology across various sectors facing PFAS challenges.

#Statements from Leadership

Randall Moore, President of BioLargo Water, emphasized the technological breakthrough by stating, "Ultrashort-chain PFAS are among the most challenging to capture and remove. Our AEC technology has now demonstrated the ability to eliminate these compounds with unprecedented efficiency." CEO Dennis P. Calvert referred to the findings as a "game-changer" for industries and communities confronting PFAS pollution.

#Key Takeaways

  • BioLargo has achieved over 99% removal of ultrashort-chain PFAS, including TFA, using its AEC technology.
  • Research indicates TFA represents a major contaminant in drinking water sources, calling for effective treatment solutions.
  • The AEC method operates sustainably without generating harmful waste, enhancing its environmental appeal.
  • BioLargo is actively pursuing commercial opportunities to implement this technology across various sectors in North America.
  • The technology positions BioLargo as a leader in PFAS remediation efforts, addressing significant contamination challenges.

Original source: Read original article

Frequently Asked Questions

BioLargo has achieved over 99% removal efficiency of ultrashort-chain PFAS, including trifluoroacetic acid (TFA), through its proprietary Aqueous Electrostatic Concentration technology. This positions the company as a leader in treating challenging contaminants that traditional methods struggle to address.
The AEC technology has demonstrated a consistent removal rate exceeding 99% for TFA and other ultrashort-chain PFAS, backed by both internal and third-party testing. Such performance indicates significant potential for widespread application in PFAS remediation efforts.
The findings suggest a breakthrough in managing PFAS contamination, especially concerning persistent compounds like TFA. By effectively addressing these, BioLargo's technology could significantly benefit communities and industries dealing with PFAS challenges.
BioLargo's AEC technology utilises electrostatic forces for selective contaminant removal, allowing for more efficient and concentrated treatment of PFAS compared to traditional methods, which often struggle with ultrashort-chain compounds.
BioLargo is actively engaging with potential partners and customers to expand its commercial activities, reflecting a strategic move to leverage its technology in the growing market for PFAS remediation.
The study highlights TFA as a major contaminant in drinking water sources, accounting for over 90% of PFAS mass analyzed. This underscores the urgency for effective treatment solutions like those offered by BioLargo.
BioLargo's AEC technology operates without generating harmful byproducts or secondary waste streams, presenting a sustainable solution for PFAS remediation that aligns with environmental protection goals.
Yes, BioLargo's AEC technology is currently being deployed commercially in North America, demonstrating its readiness for real-world applications in addressing PFAS contamination.